Healthcare

Request for TOC Request for Sample
BUY NOW

Global Endoscopic Hemostasis Market – Industry Trends and Forecast to 2028

Healthcare | Upcoming Report | Nov 2021 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Endoscopic Hemostasis Market, By Type (Mechanical Devices, Injection Devices, Thermal Devices, Topical Devices), Indications (Upper Gastrointestinal Bleeding Diseases, Lower Gastrointestinal Bleeding Diseases, Others), End User (Hospitals, Specialty Clinics, Ambulatory Centers, Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights: Global Endoscopic Hemostasis Market

Endoscopic hemostasis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 8.50% in the above-mentioned forecast period.

 Endoscopic Hemostasis is a medical procedure for the management of gastrointestinal (GI) bleeding. The hemostasis treatment is performed using an endoscope which is why it is referred as endoscopic hemostasis. The other types of devices used for the procedure are mechanical devices, injection devices, thermal devices and topical devices.

The growing prevalence of gastrointestinal (GI) bleeding is primary factor responsible for driving the growth of the endoscopic hemostasis market. Additionally, the increasing awareness among healthcare professionals regarding the advantages of endoscopic hemostasis and growing demand for endoscopic hemostasis techniques also heightens the market's overall growth. However, high cost of endoscopic hemostasis are estimated to obstruct the market’s growth.

The recent technological advancement in hemostatic clip designs which helps to achieve more effective and durable mechanical hemostasis are expected to generate profitable opportunities for the market. On the other hand, the inability to use another modality pose as challenge for the market’s growth.

This endoscopic hemostasis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research endoscopic hemostasis market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Endoscopic Hemostasis Market Scope and Market Size

Endoscopic hemostasis market is segmented on the basis of type, indications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the endoscopic hemostasis market is segmented into mechanical devices, injection devices, thermal devices and topical devices. The mechanical devices are sub-segmented into clips, ligation devices, suturing devices and stents. The thermal devices are sub-segmented into hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation and cryotherapy.
  • On the basis of indications, the market is segmented into upper gastrointestinal bleeding diseases, lower gastrointestinal bleeding diseases and others. The upper gastrointestinal bleeding diseases is sub-segmented into peptic ulcer bleeding and variceal bleeding. The lower gastrointestinal bleeding diseases is sub-segmented into diverticular bleeding and benign anorectal bleeding. The others include esophagitis, mallory-weiss syndrome, dieulafoy's lesion, post-polypectomy bleeding, vascular ectasia and radiation proctitis, inflammatory bowel disease.
  • On the basis of end user, the endoscopic hemostasis market is segmented into hospitals, specialty clinics, ambulatory centers, surgical centers and others.

Endoscopic Hemostasis Market Country Level Analysis

Endoscopic hemostasis market is analyzed and market size insights and trends are provided by type, indications and end user as referenced above.

The countries covered in the endoscopic hemostasis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the endoscopic hemostasis market due to the prevailing sophisticated level of healthcare facilities. Asia-Pacific on the other hand, is anticipated to show a rapid and lucrative growth rate in the forecast period of 2021 to 2028 owing to increased expenditure on healthcare infrastructure, ever-rising geriatric population, and increasing personal disposable income within this region.

The country section of the endoscopic hemostasis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Endoscopic hemostasis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for endoscopic hemostasis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endoscopic hemostasis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Endoscopic Hemostasis Market Share Analysis

Endoscopic hemostasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to endoscopic hemostasis market.

The major players covered in the endoscopic hemostasis market report are Boston Scientific Corporation , CONMED Corporation, Cook, Diversatek, Inc., Olympus Corporation, STERIS, Micro-Tech Endoscopy, Integra LifeSciences, Sklar Surgical Instruments, Merit Medical Systems, Abbott, Siemens, ELI Tech Group, HORIBA, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nova Biomedical, Sysmex Corporation, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3200.00
  • 8000.00
  • 15000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19